Login


TI Ref No : 519609966
Description : Contract Awarded For 2023/0491-brentuximab Vedotina [50 Mg; Pó Conc Sol Inj; Frs] (b539) brentuximab Vedotina [50 Mg; Pó Conc Sol Inj; Frs] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :17/03/2025 estimated Value Exc
Date : 2025-06-25
Deadline : 2025-09-17
Document Type : Contracts
View Details
Whats app